Very excited to announce the official launch of OverT Bio with $16M in initial financing. With this capital, we are leveraging high-throughput genomics platforms to develop the optimal cell therapy products for solid tumors. We are committed to bringing curative therapies to patients who have been failed by the current standard of care. https://lnkd.in/ebb3pX4b